VitriVax $17.25M Sales Trigger Playbook
VitriVax scores $17.25M. Cold-chain pain = your next touch. Pitch biomanufacturing + compliance. Fuel pipeline. Boost commission.
Published on
Do not index
Do not index
🚀 Battle Card: VitriVax
Quick trigger:
👤 Decision Maker in the News
- Romulo Colindres, CEO 📧 RColindres@vitrivaxbio.com
💡 Why It Matters
- This VitriVax sales trigger highlights fresh capital to accelerate thermostable vaccine development and expand global accessibility. → Source
🎯 Core Pain Point
- Cold‐chain logistics gaps hindering distribution to remote regions
- Scale-up complexities in manufacturability of novel formulations
💰 What to Pitch
- Primary: Scalable biomanufacturing platform → Faster time-to-market & reduced CapEx
- Expansion: Regulatory compliance analytics → Streamlined approvals & audit readiness
🗺️ Quick Context
- HQ: Boulder, CO
- Employees: ≈ 50
- Rev: ≈ $8M
- Website: vitrivaxbio.com
🤼 Competitive Intel
Which other vendors you’ll probably face to win VitriVax’s business.
- Veeva Systems — CRM for life sciences
- Unique edge: Industry-specific compliance & data models
- Evaluated by VP Sales for regulatory-aligned CRM
- Salesforce — Health Cloud & CRM
- Unique edge: Scalable, AI-driven lead management
- Evaluated by Sales Ops for integration
- Thermo Fisher Scientific — Formulation & fill/finish
- Unique edge: End-to-end pharma services
- Evaluated by Head of Product for scalability
- Lonza — CDMO & biologics manufacturing
- Unique edge: Global network & cell therapy expertise
- Evaluated by CTO for capacity & quality
- Catalent — Biologics development & delivery
- Unique edge: Advanced delivery tech & regulatory support
- Evaluated by VP Ops for time-to-market
✅ Do-Now Checklist
Connect with all decision makers on LinkedIn (links above)
Leverage this VitriVax sales trigger in your email & DM using the Copy-My-Prompt block (Step 7)
Schedule follow-ups in CRM (Day 3 & Day 10)
Next Step
Get VitriVax sales trigger intel like this daily—no fluff, all pipeline.
Subscribe to NewsletterForLeads
Stay on top of every VitriVax sales trigger—subscribe now!
🧠 Copy My Prompt for Personalized Cold Outreach
────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY = ❑≈ TBD❑
OFFER_BRIEF = ❑Scalable biomanufacturing platform❑
PROOF_METRIC = ❑30% CapEx reduction❑
CTA_STYLE = ❑quick_call❑
TONE = ❑punchy❑
────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME = Romulo
COMPANY = VitriVax
DEPT = Manufacturing
SIZE = 50
BOTTLENECK = cold-chain logistics gaps
EVENT = Series B financing
DETAIL = raised $17.25M in Series B financing
PAIN = cold-chain logistics hindering distribution
SRC = https://vcnewsdaily.com/vitrivax/venture-capital-funding/fzfcxwnswt
SIM_CO = Lonza
WIN_METRIC = 40% faster scale-up
NEXT_SIZE = 100
EMP_EST = ≈ 50
REV_EST = ≈ $8M
────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.
EMAIL (keep breaks):
Subject: 50-person Manufacturing
Romulo—noticed your Manufacturing team is ≈ 50.
That’s when cold-chain logistics gaps slows growth.
We helped Lonza fix this with Scalable biomanufacturing platform.
Result: 40% faster scale-up.
Quick call?
PS—next bottleneck hits ≈ 100.
DM ≤45 words, TONE:
Saw your post about raised $17.25M in Series B financing — cold-chain logistics hindering distribution.
Scalable biomanufacturing platform. 30% CapEx reduction.
Quick chat?